iHuman Inc. (IH)
iHuman Statistics
Share Statistics
iHuman has 10.4M shares outstanding. The number of shares has increased by -1.22% in one year.
| Shares Outstanding | 10.4M |
| Shares Change (YoY) | -1.22% |
| Shares Change (QoQ) | -0.39% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 15.22M |
| Failed to Deliver (FTD) Shares | 1.76K |
| FTD / Avg. Volume | 2.14% |
Short Selling Information
The latest short interest is 14.92K, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 14.92K |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.08% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 6.73 and the forward PE ratio is null. iHuman's PEG ratio is 0.11.
| PE Ratio | 6.73 |
| Forward PE | n/a |
| PS Ratio | 1.2 |
| Forward PS | 0 |
| PB Ratio | 1.27 |
| P/FCF Ratio | 7.35 |
| PEG Ratio | 0.11 |
Enterprise Valuation
iHuman has an Enterprise Value (EV) of 4.88B.
| EV / Sales | 4.79 |
| EV / EBITDA | 28.44 |
| EV / EBIT | 28.35 |
| EV / FCF | 29.46 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.
| Current Ratio | 2.82 |
| Quick Ratio | 2.78 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 18.89% and Return on Invested Capital is 14.85%.
| Return on Equity | 18.89% |
| Return on Assets | 12.47% |
| Return on Invested Capital | 14.85% |
| Revenue Per Employee | $1.3M |
| Profits Per Employee | $231.04K |
| Employee Count | 783 |
| Asset Turnover | 0.7 |
| Inventory Turnover | 17.97 |
Taxes
| Income Tax | 21.67M |
| Effective Tax Rate | 10.7% |
Stock Price Statistics
The stock price has increased by 13.37% in the last 52 weeks. The beta is 0.32, so iHuman's price volatility has been higher than the market average.
| Beta | 0.32 |
| 52-Week Price Change | 13.37% |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 43.59 |
| Average Volume (20 Days) | 82.27K |
Income Statement
In the last 12 months, iHuman had revenue of 1.02B and earned 180.91M in profits. Earnings per share was 0.66.
| Revenue | 1.02B |
| Gross Profit | 721.27M |
| Operating Income | 159.89M |
| Net Income | 180.91M |
| EBITDA | 171.58M |
| EBIT | 159.89M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 1.21B in cash and 3.86M in debt, giving a net cash position of 1.21B.
| Cash & Cash Equivalents | 1.21B |
| Total Debt | 3.86M |
| Net Cash | 1.21B |
| Retained Earnings | -140.46M |
| Total Assets | 1.42B |
| Working Capital | 862.41M |
Cash Flow
In the last 12 months, operating cash flow was 172.12M and capital expenditures -6.51M, giving a free cash flow of 165.61M.
| Operating Cash Flow | 172.12M |
| Capital Expenditures | -6.51M |
| Free Cash Flow | 165.61M |
| FCF Per Share | 0.6 |
Margins
Gross margin is 70.84%, with operating and profit margins of 15.7% and 17.77%.
| Gross Margin | 70.84% |
| Operating Margin | 15.7% |
| Pretax Margin | 19.9% |
| Profit Margin | 17.77% |
| EBITDA Margin | 16.85% |
| EBIT Margin | 15.7% |
| FCF Margin | 16.27% |
Dividends & Yields
IH pays an annual dividend of $0.09, which amounts to a dividend yield of 4.38%.
| Dividend Per Share | $0.09 |
| Dividend Yield | 4.38% |
| Dividend Growth (YoY) | 1.19% |
| Payout Ratio | 34% |
| Earnings Yield | 14.86% |
| FCF Yield | 2.72% |
Analyst Forecast
Currently there are no analyst rating for IH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.52 |
| Piotroski F-Score | 3 |